Just over half of Americans support US health care reform

20 August 2009

A slim majority of Americans continues to favor moving forward on health care reform now despite an intensifying ad war and a political climate of contentious town hall meetings that coincide with rising concerns about the reform effort, according to the August Kaiser Health Tracking Poll.

53% of the US public believes that tackling health reform is more important than ever, compared to 42% who say we cannot afford to take on health care reform right now. The gap between those points of view has narrowed in recent months as criticisms and doubts about reform plans seem to be registering. 63% of the public say they are "hopeful" about reform, 41% are "afraid" and 46% are simply "confused".

The August poll was conducted during a period in which politically-active members of the public vented their fears and hopes about reform plans in fiery and widely-publicized town hall meetings with elected officials, and at a time when an increasing number of Americans (45% compared to 31% in July) reported seeing advertisements having to do with proposed changes in the health care system.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight